Momentum Clinical Research NZ

19/11/2025

Today we join the global community in recognising World COPD Day, led by the Global Initiative for Chronic Obstructive Lung Disease - GOLD in partnership with health professionals and patient groups worldwide.

This year’s theme, “Short of Breath, Think COPD,” highlights an important truth:
👉 COPD is the 3rd leading cause of death worldwide, yet it often goes undiagnosed or misdiagnosed.
👉 Early diagnosis can significantly improve symptoms, lung function, and overall quality of life.
COPD may be under-recognised, but it is preventable and treatable. A diagnosis should be considered in people with:
🌬 Shortness of breath
🌬 Chronic cough or sputum
🌬 Frequent chest infections
🌬 Exposure to smoke, cooking fuels, or workplace hazards

At Momentum Clinical Research, we are committed to advancing research that helps improve diagnosis, treatment, and future care options for people living with chronic respiratory conditions.
Let’s raise awareness, encourage earlier detection, and support those affected.

Together we can reduce the burden of COPD. One conversation, one diagnosis, one study at a time.
📅 World COPD Day | November 19

18/09/2025

Why clinical research matters – and how you can be part of it
At Momentum Clinical Research, everything we do starts with people like you.

This is Bruno’s story. He took part in a clinical trial with us and found it not only helped him personally, but also gave him the satisfaction of knowing he was contributing to something bigger – helping bring a new medication to others who need it.

Every clinical trial relies on participants who are willing to take part. Your involvement has the power to move medicine forward, to create options for people who don’t yet have them, and to make a real difference in the lives of others.

If you’ve ever wondered what it’s like to be part of a clinical trial, or how you can help advance future medicines, stories like Bruno’s show just how impactful your involvement can be.
Together, we’re shaping the future of healthcare.

www.momentumclinicalresearch.com/clinical-trials/

06/06/2024

P3 Research has united with Australia’s renowned AusTrials and Holdsworth House to form Momentum Clinical Research.

P3 Research’s name will change to Momentum Clinical Research from the 1st of July 2024.

What does this mean for our Participants?
Our Momentum network of 13 sites across New Zealand and Australia enables us to bring more research studies to the region and help accelerate the development of new medicines that are needed by our communities.

Our Mission: To deliver people-centered research and clinical excellence at scale, making meaningful, positive impact in people's lives.

Our promise to you:
We will continue to provide the same local expertise, care and ethical processes but with support from a wider Australasian network.

Rest assured, our name may be changing but our studies will continue to follow the same ethical processes and deliver the same exceptional care by our local experts.

If you are currently enrolled in a study with P3 Research, there will be no change to your clinical visits, contacts or the design of the study you are involved in. If you do have any questions, please contact your study coordinator.

We are excited to begin this new chapter alongside the partners and participants that we have worked with over the past 20 years.

Learn more about Momentum Clinical Research here. www.momentumclinicalresearch.com

20/05/2024

Today at P3 Research we celebrate the scientists, researchers, healthcare professionals, and participants who make clinical trials and medical advancement possible.

Chief Medical Officer, Prof Richard Stubbs spoke last week to Radio NZ to discuss the tremendously rewarding work conducted by Momentum staff across the 13 research sites in New Zealand and Australia.

"Our staff are doctors and nurses from all around the country who are incredibly enthusiastic and passionate about the work we do. We think what we do is important and will bring forward the day that there will be better medications for a vast majority of conditions."

Dr Stubbs also spoke about the prevalence of rare disorders in New Zealand and the multiple barriers to treatment that these patients face including limited access to publicly funded medicine.

Listen to the full interview here:
https://loom.ly/JSPB0t8

"Clinical trials can provide an opportunity for individuals to gain access to the best available medicines today and potentially to investigational medicines that could prove to be even better. "

"Our spread of research sites across NZ and Australia means if there are clinical trials or new medications coming available, then through our network we can take them to where people live. Therefore the opportunity to participate in clinical trials for relatively rare conditions becomes an option."

Clinical trials have come a long way since 1774 when James Lind, a ship's surgeon in the British Royal Navy started what is often considered to be the first randomized clinical trial. Lind found a cure for scurvy after carrying out a clinical trial in just 12 people, of whom two received the active treatment of citrus fruit to treat the disease caused by vitamin C deficiency.

Happy International Clinical Trials Day from P3 Research!

14/05/2024

Yesterday at Momentum Clinical Research, we celebrated International Nurses Day, a time dedicated to honouring the extraordinary contributions of nurses worldwide. It serves as a moment for us to reflect on the significant impact they have on our lives and communities, paying tribute to the enduring legacy of Florence Nightingale and the relentless commitment of nurses everywhere.

We celebrated the exceptional work of our nurses across Momentum Clinical Research's 13 clinical trial sites in New Zealand and Australia. To learn more about Momentum's capabilities and how we can streamline and accelerate your research please visit https://loom.ly/-TEuS2w

23/04/2024

We enjoyed chatting with women at the WWL Expo. We talked about the benefits of participating in research studies and how it may enable you to contribute to medical advancements that are needed in your community. We signed up over 70 wonderful women who would like to be on our database for future studies.

If you missed the event but would like to sign up to learn more about participating in a research study, click here: https://shorturl.at/afNOQ

04/04/2024

Tag a friend you’d love to explore the Wellington Women’s Lifestyle Expo with, for a chance to win 1 of 4 double passes!

🗓️ Saturday 13th & Sunday 14th April

P3 Research will be there. Discover how participating in a clinical study can help advance medical research and positively impact our community.

06/12/2023

Our Wellington team escaped the hustle and bustle of city life on Saturday and ventured into the serene beauty of The Wairarapa for their Christmas do. The lunch at Tirohana Estate was unforgettable, nestled in the vineyards, this place is a true gem. As we close out the year, let's raise a toast to working together as a team and accomplishing so much in the past year. Here's to more success ahead.

16/10/2023

We are delighted to announce the latest additions to our Dunedin team, Melanie Gaffaney and Dr Brendan O'Neil. Joining the team in the "Escape Room" challenge were Dr Richard Stubbs, Managing Director, and Katie Kennett, Operations Manager. P3 Research Dunedin is looking forward to achieving many more milestones, growth, and success together. In the picture from left to right: Dr Richard Stubbs (Managing Director), Dr Sarah Hortop (Investigator), Michelle Berland (SC), Melanie Gaffaney (SC), Marie-Michelle Sullivan (Unit Manager), Caroline Ancel (SC), Brendan O’Neill (Investigator) and Katie Kennett (Operations Manager).

05/09/2023

P3 Research was a proud gold sponsor at the recent NZACRes 2023 conference in Auckland. Two members of staff from each of our seven P3 units, and from our head office joined in, making great connections with colleagues, sponsors, and peers in the clinical research field. Congratulations to the NZACRes committee and conference committee, for a very good conference.

26/07/2023

Early in June, our clinical team from five of our P3 sites attended an Investigators Meeting in Bangkok. Dr Andrew Edwards was invited to join the panel of guest speakers to share his knowledge, experience, and strategies as primary investigator in the E.mbrace Urinary Tract Infection study. We are pleased that our new site in Dunedin has also been selected to join this study, bringing the total number of participating P3 Research sites to six. If you want to find out more about enrolling in our Urinary Tract Infection study, contact us on 0800 737 883 and select a participating P3 site nearest to you.

18/04/2023

Exciting job opportunity for a research nurse to join our P3 team in Hawkes Bay.

Exciting opportunity for a registered nurse to take on a new role as a study coordinator in the field of clinical research.